Clinical trial

REDUCE LAP-HF TRIAL II

NCT03088033

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-06-01

PhaseNA

Study timeline

Study start (actual)2017-06-01Date precision: day

Registry last updated2023-02-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

IASD System II implantDEVICE

intra-cardiac echocardiography (ICE), or transesophageal echocardiography (TEE)OTHER

Sponsors & collaborators

Corvia Medicallead sponsor

Mapped research locations

HoustonTexas, United States2 BostonMassachusetts, United States2 ChicagoIllinois, United States2 ParisFrance2 ColumbusOhio, United States2 BerlinGermany2 HamburgGermany2 La JollaCalifornia, United States2 OsakaJapan2 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03088033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.